ID
33351
Beschrijving
Efficacy and Safety of BMS-690514 in Combination With Letrozole to Treat Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01068704
Link
https://clinicaltrials.gov/show/NCT01068704
Trefwoorden
Versies (1)
- 06-12-18 06-12-18 -
Houder van rechten
See clinicaltrials.gov
Geüploaded op
6 december 2018
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Breast Cancer NCT01068704
Eligibility Breast Cancer NCT01068704
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
Prior Hormone Therapy Neoplasm Metastasis
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C1514460
- UMLS CUI [1,2]
- C0027627
Beschrijving
Prior Hormone Therapy Letrozole | Other Coding
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C1514460
- UMLS CUI [1,2]
- C0246421
- UMLS CUI [2]
- C3846158
Beschrijving
Metastatic malignant neoplasm to brain Symptomatic
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0220650
- UMLS CUI [1,2]
- C0231220
Beschrijving
Tyrosine kinase inhibitor
Datatype
boolean
Alias
- UMLS CUI [1]
- C1268567
Similar models
Eligibility Breast Cancer NCT01068704
- StudyEvent: Eligibility
C0439165 (UMLS CUI [1,2])
C0279754 (UMLS CUI [1,3])
C0597032 (UMLS CUI [2,1])
C0439165 (UMLS CUI [2,2])
C0279759 (UMLS CUI [2,3])
C2348909 (UMLS CUI [1,2])
C0012634 (UMLS CUI [2,1])
C2348908 (UMLS CUI [2,2])
C0039286 (UMLS CUI [2])
C0290883 (UMLS CUI [3])
C0851344 (UMLS CUI [4])
C0027627 (UMLS CUI [1,2])
C0246421 (UMLS CUI [1,2])
C3846158 (UMLS CUI [2])
C0231220 (UMLS CUI [1,2])